Jump Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16M | Buy |
291,217
+245,017
| +530% | +$13.5M | 0.18% | 126 |
|
|
2025
Q1 | $3.27M | Buy |
46,200
+41,769
| +943% | +$2.95M | 0.04% | 433 |
|
|
2024
Q4 | $291K | Sell |
4,431
-15,539
| -78% | -$1.02M | 0.01% | 1315 |
|
|
2024
Q3 | $1.4M | Buy |
+19,970
| New | +$1.4M | 0.03% | 653 |
|
|
2024
Q2 | – | Sell |
-3,200
| Closed | -$279K | – | 1819 |
|
|
2024
Q1 | $279K | Buy |
3,200
+707
| +28% | +$61.7K | 0.01% | 1477 |
|
|
2023
Q4 | $240K | Sell |
2,493
-6,366
| -72% | -$614K | 0.01% | 1455 |
|
|
2023
Q3 | $784K | Sell |
8,859
-60,719
| -87% | -$5.37M | 0.03% | 788 |
|
|
2023
Q2 | $6.03M | Buy |
+69,578
| New | +$6.03M | 0.22% | 86 |
|
|
2022
Q4 | – | Sell |
-4,711
| Closed | -$400K | – | 1588 |
|
|
2022
Q3 | $400K | Sell |
4,711
-3,365
| -42% | -$286K | 0.02% | 991 |
|
|
2022
Q2 | $670K | Sell |
8,076
-45,385
| -85% | -$3.77M | 0.03% | 726 |
|
|
2022
Q1 | $4.12M | Buy |
53,461
+48,813
| +1,050% | +$3.76M | 0.18% | 108 |
|
|
2021
Q4 | $411K | Sell |
4,648
-16,452
| -78% | -$1.45M | 0.03% | 743 |
|
|
2021
Q3 | $1.63M | Buy |
+21,100
| New | +$1.63M | 0.12% | 194 |
|